In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549

Experimental Lung Research

Volumn 32, Issue 9, 2006, Pages 441-453

  Waheed Roomi, M ^a   Ivanov, Vadim ^a   Kalinovsky, Tatiana ^a   Niedzwiecki, Aleksandra ^a   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

A 549; Antitumor effect; Lung cancer; MMP; Nutrient mixture

Indexed keywords

ACETYLCYSTEINE; ARGININE; ASCORBIC ACID; CALCIUM; COPPER; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; LYSINE; MAGNESIUM; MANGANESE; MATRIGEL; MATRIX METALLOPROTEINASE; PALMITIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROLINE; SELENIUM; TRACE ELEMENT;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; ENZYME RELEASE; HUMAN; HUMAN CELL; LUNG CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; NUTRIENT SOLUTION; PRIORITY JOURNAL; TUMOR VOLUME; ZYMOGRAPHY;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCORBIC ACID; CAMELLIA SINENSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LAMININ; LUNG NEOPLASMS; LYSINE; MICE; MICE, NUDE; PLANT EXTRACTS; PROLINE; PROTEOGLYCANS;

EID: 33845660233     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140601047658     Document Type: Article

References (36)

1. American Cancer Society: Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
3. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH: Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients. J Clin Oncol. 1995;13:1215-1220.
4. Potosky AL, Saxman S, Wallace RB, Lynch CF: Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004;22:3261-3268.
5. Souquet PJ, Tan EH, Rodrigues Pereira J, Van Klaveren R, Price A, Gatzeimeier U, Jaworski M, Burillon JP, Aubert D: GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol. 2002;13:1853-1861.
6. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A: Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health. 2003;66:469-479.
7. Quasthoff S, Hartung HP: Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249:9-17.
8. Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL: Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol. 2005;23:8597-8605.
9. Guerra J, De Jesus A, Santiago-Borrero P, Roman-Franco A, Rodriguez E, Crespo MJ: Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats. Hematol J. 2005;5:584-588.
10. Yanez JA, Teng XW, Roupe KA, Fariss MW, Davies NM: Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Sci. 2003;6:308-314.
11. Kachel DL, Martin WJ 2nd: Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther. 1994;268:42-46.
12. Rath M, Pauling L: Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomol Med. 1992;7:17-23.
13. Roomi MW, Roomi N, Ivanov V, Netke S, Kalinovsky T, Niedzwiecki A, Rath M. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058. In Vivo 2006; 20:25-32.
14. Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res. 2005;7:R291-R295.
15. Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M: Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep. 2005;14:807-815.
16. Harakeh S, Diab-Assaf M, Niedzwiecki A, Khalife J, Abu-El-Ardat K, Rath M: Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells. Leuk Res. 2006;30:869-881.
17. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H: Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells. Anticancer Res. 2001;21:213-219.
18. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Floro S, D'Agostinin F, Albini A, Fassima G: The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 1999;14:268-271.
19. Yoon SO, Kim MM, Chung AS: Inhibitory effects of selenite on invasion of HT 1080 tumor cells. J Biol Chem. 2001;276:20085-20092.
20. Maramag C, Menon M, Balaji KC, Reddy PG, Laxmanan S: Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. Prostate. 1997;32:188-195.
21. Chen Q, Espey MG, Krishma M, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005;102:13604-13609.
22. Hare Y: Green Tea: Health Benefits and Applications. New York, Basel: Marcel Dekker; 2001.
23. Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997;48:489-509.
24. Roomi MW, Ivanov V, Niedzwiecki A, Rath M: Synergistic antitumor effect of ascorbic acid, lysine, proline, and epigallocatechin gallate on human fibrosarcoma cells HT-1080. Ann Cancer Res Ther. 2004;12:148-157.
25. Almholt K, Lund LR, Rygaard J, Nielsen BS, Dano K, Romer J, Johnson M: Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice. Int J Cancer. 2005;113:525-532.
26. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992;10:145-155.
27. Naidu KA, Karl RC, Coppola D: Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci. 2003;48:230-237.
28. Anthony HM, Schorah CJ: Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte related host resistance. Br J Cancer. 1982;46:354-367.
29. Koh WS, Lee SJ, Lee H, Park C, Park MH, Kim WS, Yoon SS, Park K, Hong SI, Chung MH, Park CH: Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res. 1998;18:2487-2493.
30. Glaab WE, Hill RB, Skopek TR: Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells. Carcinogenesis. 2001;22:1709-1713.
31. Nunez C, Ortiz de Apodaca Y, Ruiz A: Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutr Hosp. 1995;10:368-372.
32. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW: Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 1996;103:183-189.
33. Cao Y, Cao R: Angiogenesis inhibited by drinking tea. Nature. 1999;398:381.
34. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst. 1997;89:1881-1886.
35. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A: Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 2001;91:822-832.
36. Roomi MW, Ivanov V, Netke SP, Niedzwiecki A, Rath M: Serum markers of the liver, heart, and kidney and lipid profile and histopathology in ODS rats treated with nutrient synergy. J Am Coll Nutr. 2003;22:477, Abstract 86.